Published in ChemMedChem on November 12, 2014
TAMH: A Useful In Vitro Model for Assessing Hepatotoxic Mechanisms. Biomed Res Int (2016) 0.75
Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med (2005) 12.03
Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation (2003) 2.59
Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res (2003) 2.56
Structural and mechanistic basis of pre- and posttransfer editing by leucyl-tRNA synthetase. Mol Cell (2003) 2.41
Pulsatile venoarterial perfusion using a novel synchronized cardiac assist device augments coronary artery blood flow during ventricular fibrillation. Artif Organs (2014) 1.99
Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation (2003) 1.61
Synthesis, X-ray crystal structures, stabilities, and in vitro cytotoxic activities of new heteroarylacrylonitriles. J Med Chem (2004) 1.57
Transferring the concept of multinuclearity to ruthenium complexes for improvement of anticancer activity. J Med Chem (2009) 1.51
Role of receptor for advanced glycation end products in cardiogenic shock. Crit Care Med (2012) 1.46
Beneficial association of β-blocker therapy on recovery from severe acute heart failure treatment: data from the Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support trial. Crit Care Med (2011) 1.45
Studies of the in vitro anticancer, antimicrobial and antioxidant potentials of selected Yemeni medicinal plants from the island Soqotra. BMC Complement Altern Med (2009) 1.29
Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease. Basic Res Cardiol (2007) 1.28
Exclusive platination of loop adenines in the human telomeric G-quadruplex. Org Biomol Chem (2009) 1.07
Synthesis of beta- and gamma-oxa isosteres of fosmidomycin and FR900098 as antimalarial candidates. Bioorg Med Chem (2007) 1.00
Cognitive function in patients with decompensated heart failure: the Cognitive Impairment in Heart Failure (CogImpair-HF) study. Eur J Heart Fail (2012) 0.98
Results of a consensus meeting on the use of argatroban in patients with heparin-induced thrombocytopenia requiring antithrombotic therapy - a European Perspective. Thromb Res (2011) 0.95
Total-to-ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients. Crit Care (2012) 0.95
Correlations between the activities of 19 anti-tumor agents and the intracellular glutathione concentrations in a panel of 14 human cancer cell lines: comparisons with the National Cancer Institute data. Anticancer Drugs (2006) 0.95
N-acyl-N-alkyl-sulfonamide anchors derived from Kenner's safety-catch linker: powerful tools in bioorganic and medicinal chemistry. Bioorg Med Chem (2005) 0.91
Towards new antimalarial drugs: synthesis of non-hydrolyzable phosphate mimics as feed for a predictive QSAR study on 1-deoxy-D-xylulose-5-phosphate reductoisomerase inhibitors. Chem Biodivers (2008) 0.91
Endogenous plasma activated protein C levels and the effect of enoxaparin and drotrecogin alfa (activated) on markers of coagulation activation and fibrinolysis in pulmonary embolism. Crit Care (2011) 0.89
Synthesis, crystal structure and biological activities of copper(II) complexes with chelating bidentate 2-substituted benzimidazole ligands. J Inorg Biochem (2006) 0.89
Studies of the mechanism of action of platinum(II) complexes with potent cytotoxicity in human cancer cells. J Med Chem (2009) 0.87
Angiopoietin-2 and outcome in patients with acute decompensated heart failure. Clin Res Cardiol (2014) 0.85
Antimalarial activity of n(6)-substituted adenosine derivatives (part 2). J Comb Chem (2002) 0.85
Trans,trans,trans-[PtIV(N3)2(OH)2(py)(NH3)]: a light-activated antitumor platinum complex that kills human cancer cells by an apoptosis-independent mechanism. Mol Cancer Ther (2012) 0.84
Synthesis and biological activity of splitomicin analogs targeted at human NAD(+)-dependent histone deacetylases (sirtuins). Bioorg Med Chem (2011) 0.83
FGF-23 is associated with increased disease severity and early mortality in cardiogenic shock. Eur Heart J Acute Cardiovasc Care (2013) 0.83
Anticancer activity and mode of action of titanocene C. Invest New Drugs (2010) 0.82
Identification of a glutathione peroxidase inhibitor that reverses resistance to anticancer drugs in human B-cell lymphoma cell lines. Bioorg Med Chem Lett (2012) 0.82
Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Crit Care (2014) 0.82
Aroyl hydrazones of 2-phenylindole-3-carbaldehydes as novel antimitotic agents. Bioorg Med Chem (2008) 0.81
Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020. Eur J Pharm Sci (2012) 0.81
Anti-malarial activity of N(6)-substituted adenosine derivatives. Part I. Bioorg Med Chem (2002) 0.81
Synthesis, structural characterization, and in vitro antitumor activity of novel N-(6-chloro-1,1-dioxo-1,4,2-benzodithiazin-3-yl)arylsulfonamides. Bioorg Med Chem (2007) 0.81
Long-term follow-up of early versus delayed invasive approach after fibrinolysis in acute myocardial infarction. Circ Cardiovasc Interv (2011) 0.81
Potential role of dendritic cells in atherogenesis. Cardiovasc Res (2002) 0.81
Investigation of the in vitro metabolism of the analgesic flupirtine. Drug Metab Dispos (2008) 0.80
No correlation between GSH levels in human cancer cell lines and the cell growth inhibitory activities of platinum diamine complexes. Arch Pharm (Weinheim) (2004) 0.80
A timely reassessment of early prediction in the bioavailability of orally administered drugs. Angew Chem Int Ed Engl (2005) 0.80
Ischaemia-induced up-regulation of Toll-like receptor 2 in circulating monocytes in cardiogenic shock. Eur Heart J (2011) 0.80
Chiral platinum(II) metallointercalators with potent in vitro cytotoxic activity. ChemMedChem (2007) 0.80
Cytotoxic saponins from the seeds of Pittosporum angustifolium. Z Naturforsch C (2014) 0.79
DNA binding studies and cytotoxicity of a dinuclear PtII diazapyrenium-based metallo-supramolecular rectangular box. Chemistry (2012) 0.79
Influence of pyridine versus piperidine ligands on the chemical, DNA binding and cytotoxic properties of light activated trans,trans,trans-[Pt(N3)2(OH)2(NH3)(L)]. J Inorg Biochem (2011) 0.79
Polymer-bound reagents for the introduction of spacer-modified biotin labels. Bioorg Med Chem (2004) 0.79
The Th17/Treg imbalance in patients with cardiogenic shock. Clin Res Cardiol (2013) 0.78
[(2-Phenylindol-3-yl)methylene]propanedinitriles inhibit the growth of breast cancer cells by cell cycle arrest in G(2)/M phase and apoptosis. Bioorg Med Chem (2007) 0.78
3,5,7,9-Substituted hexaazaacridines: toward structures with nearly degenerate singlet-triplet energy separations. J Org Chem (2008) 0.78
Matrix compare analysis discriminates subtle structural differences in a family of novel antiproliferative agents, diaryl-3-hydroxy-2,3,3a,10a-tetrahydrobenzo[b]cycylopenta[e]azepine-4,10(1H,5H)-diones. Bioorg Med Chem Lett (2006) 0.78
Synthesis and cytotoxic activity of imidazo[1,2-a]-1,3,5-triazine analogues of 6-mercaptopurine. Arch Pharm (Weinheim) (2008) 0.78
Triterpene glycosides from the leaves of Pittosporum angustifolium. Planta Med (2013) 0.78
Synthesis, enzymatic evaluation, and docking studies of fluorogenic caspase 8 tetrapeptide substrates. ChemMedChem (2010) 0.78
Improving an antitrypanosomal lead applying nucleophilic substitution on a safety catch linker. Bioorg Med Chem (2002) 0.78
Antimalarial activity of N(6)-substituted adenosine derivatives. Part 3. Bioorg Med Chem (2004) 0.77
Synthesis, crystal structure, cytotoxic and superoxide dismutase activities of copper(II) complexes of N-(4,5-dihydroimidazol-2-yl)azoles. Arch Pharm (Weinheim) (2007) 0.77
Studies on the photoactivation of two cytotoxic trans,trans,trans-diazidodiaminodihydroxo-Pt(IV) complexes. Dalton Trans (2011) 0.77
Correlations between the activities of 19 standard anticancer agents, antioxidative enzyme activities and the expression of ATP-binding cassette transporters: comparison with the National Cancer Institute data. Anticancer Drugs (2007) 0.77
Structure-activity relationships of targeted RuII(η6-p-cymene) anticancer complexes with flavonol-derived ligands. J Med Chem (2012) 0.77
Nicotinamide adenine dinucleotide phosphate-regenerating system coupled to a glutathione-reductase microtiter method for determination of total glutathione concentrations in adherent growing cancer cell lines. Anal Biochem (2003) 0.77
Synthesis and antiplasmodial activity of new N-[3-(4-{3-[(7-chloroquinolin-4-yl)amino]propyl}piperazin-1-yl)propyl]carboxamides. Bioorg Med Chem (2006) 0.77
Structure-activity relationships of novel heteroaryl-acrylonitriles as cytotoxic and antibacterial agents. Eur J Med Chem (2007) 0.77
Synthesis of a hydrolytically stable, fluorescent-labeled ATP analog as a tool for probing adenylyl cyclases. Bioorg Med Chem Lett (2009) 0.76
Advances in the design of a multipurpose fragment screening library. Expert Opin Drug Discov (2013) 0.76
Synthesis of indirubin-N'-glycosides and their anti-proliferative activity against human cancer cell lines. Bioorg Med Chem (2008) 0.76
Circulating microparticles in septic shock. Am J Respir Crit Care Med (2009) 0.76
Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents. Anticancer Drugs (2009) 0.76
Quantification of elastase-like activity in 13 human cancer cell lines and in an immortalized human epithelial cell line by RP-HPLC. Biol Chem (2003) 0.76
Dancing of the second aromatic residue around the 6,8-diazabicyclo[3.2.2]nonane framework: influence on sigma receptor affinity and cytotoxicity. J Med Chem (2009) 0.76
Dyspnoea in a patient with chronic heart failure: surprise, surpise! BMJ Case Rep (2009) 0.75
Telmisartan in high-risk patients intolerant of ACE inhibitors. Lancet (2009) 0.75
Metabolic activation and analgesic effect of flupirtine in healthy subjects, influence of the polymorphic NAT2, UGT1A1 and GSTP1. Br J Clin Pharmacol (2015) 0.75
Synthesis of bicyclic sigma receptor ligands with cytotoxic activity. J Med Chem (2007) 0.75
Microwave-assisted synthesis and evaluation of acylhydrazones as potential inhibitors of bovine glutathione peroxidase. Mol Divers (2014) 0.75
Synthesis of novel aryl(heteroaryl)sulfonyl ureas of possible biological interest. Molecules (2010) 0.75
Tractable synthesis of multipurpose screening compounds with under-represented molecular features for an open access screening platform. Mol Divers (2014) 0.75
Synthesis, pharmacological evaluation, and σ1 receptor interaction analysis of hydroxyethyl substituted piperazines. J Med Chem (2014) 0.75
Synthesis and pharmacological evaluation of SNC80 analogues with a bridged piperazine ring. ChemMedChem (2009) 0.75
Dynamite approach to delicate complex scaffolds. Drug Discov Today (2002) 0.75
Synthesis and biological activity of some 2-imidazolinylhydrazone derivatives. Acta Pol Pharm (2009) 0.75
5'-Deoxy congeners of 9-(3-amido-3-deoxy-beta-D-xylofuranosyl)-N(6)-cyclopentyladenine: new adenosine A(1) receptor antagonists and inverse agonists. J Med Chem (2002) 0.75
Evaluation of (S)- and (R)-misonidazole as GPX inhibitors: synthesis, characterization including circular dichroism and in vitro testing on bovine GPx-1. Arch Pharm (Weinheim) (2013) 0.75
[Nitric oxide donors in the treatment of cardiac insufficiency]. Pharm Unserer Zeit (2010) 0.75
1,2,4-trisubstituted cyclopentanes as platforms for diversity. Arch Pharm (Weinheim) (2012) 0.75
4-Aminocyclopentane-1,3-diols as platforms for diversity: synthesis of anandamide analogs. Med Chem (2013) 0.75
Short synthesis of ethyl 3-(3-aminophenyl)propanoate. Arch Pharm (Weinheim) (2011) 0.75
Synthesis, cytotoxicity testing, and structure-activity relationships of novel 6-chloro-7-(4-phenylimino-4H-3,1-benzoxazin-2-yl)-3-(substituted)-1,4,2-benzodithiazine 1,1-dioxides. Arch Pharm (Weinheim) (2011) 0.75
In vitro anticancer activity and evaluation of DNA duplex binding affinity of phenyl-substituted indoloquinolines. Bioorg Med Chem Lett (2011) 0.75
Sustainable synthesis and automated deposition: an accessible discovery screening library of fragment-like purines. Mol Divers (2012) 0.75
3,5,7,9-Tetraphenylhexaazaacridine: a highly stable, weakly antiaromatic species with 16 pi electrons. Angew Chem Int Ed Engl (2005) 0.75
Cytotoxic and antimicrobial activities of Cu(II), Co(II), Pt(II) and Zn(II) Complexes with N,O-chelating heterocyclic carboxylates. Arch Pharm (Weinheim) (2011) 0.75
Synthesis and biological evaluation of conformationally restricted σ(1) receptor ligands with 7,9-diazabicyclo[4.2.2]decane scaffold. Org Biomol Chem (2010) 0.75
Inhibitors of adenosine consuming parasites through polymer-assisted N-acylation of N6-substituted 5'-amino-5'-deoxyadenosines. Mol Divers (2009) 0.75